Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
N/A
-105,551 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
N/A
84,538 Added 402.31%
105,551 $557,000
Q1 2021

May 10, 2021

BUY
N/A
21,013 New
21,013 $101,000
Q3 2020

Nov 06, 2020

SELL
N/A
-30,484 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
N/A
-5,902 Reduced 16.22%
30,484 $78,000
Q1 2020

May 12, 2020

SELL
N/A
-30,527 Reduced 45.62%
36,386 $105,000
Q4 2019

Feb 12, 2020

BUY
N/A
66,913 New
66,913 $254,000
Q3 2018

Nov 13, 2018

SELL
N/A
-8,200 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
N/A
8,200 New
8,200 $212,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.